Go Pro

Reginald Love Sells 5,091 Shares of Strata Critical Medical (NASDAQ:SRTA) Stock

Key Points

  • Director Reginald Love sold 5,091 Strata Critical Medical shares at an average price of $5.75, receiving $29,273.25 and reducing his ownership by 3.36% to 146,481 shares.
  • Strata Critical Medical shares recently traded at $5.97, with a market capitalization of approximately $516.6 million and a 12-month trading range of $3.85 to $6.50.
  • Institutional ownership stands at 47.36%, while analysts maintain a “Moderate Buy” consensus with an average price target of $8.00; Weiss Ratings separately downgraded the stock to “hold (c-).”
  • Interested in Strata Critical Medical? Here are five stocks we like better.

Strata Critical Medical (NASDAQ:SRTA - Get Free Report) Director Reginald Love sold 5,091 shares of the firm's stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $5.75, for a total value of $29,273.25. Following the completion of the transaction, the director directly owned 146,481 shares in the company, valued at $842,265.75. This trade represents a 3.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Strata Critical Medical Price Performance

Shares of NASDAQ SRTA traded down $0.06 on Thursday, hitting $5.97. The company had a trading volume of 688,509 shares, compared to its average volume of 983,054. Strata Critical Medical has a 12-month low of $3.85 and a 12-month high of $6.50. The firm has a market cap of $516.58 million, a price-to-earnings ratio of -149.25 and a beta of 2.25. The company has a 50 day moving average price of $5.44.

Hedge Funds Weigh In On Strata Critical Medical

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP increased its position in shares of Strata Critical Medical by 11.9% during the first quarter. Dimensional Fund Advisors LP now owns 1,617,104 shares of the company's stock worth $6,759,000 after acquiring an additional 172,154 shares during the last quarter. Principal Financial Group Inc. purchased a new position in Strata Critical Medical in the first quarter valued at about $537,000. Bank of America Corp DE grew its stake in Strata Critical Medical by 16.2% during the 1st quarter. Bank of America Corp DE now owns 181,574 shares of the company's stock valued at $759,000 after purchasing an additional 25,379 shares in the last quarter. Allied Private Wealth LLC acquired a new stake in Strata Critical Medical during the 2nd quarter valued at approximately $31,000. Finally, Quantinno Capital Management LP increased its holdings in Strata Critical Medical by 98.7% during the 1st quarter. Quantinno Capital Management LP now owns 143,239 shares of the company's stock worth $599,000 after purchasing an additional 71,155 shares during the last quarter. 47.36% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, Weiss Ratings downgraded shares of Strata Critical Medical from a "hold (c)" rating to a "hold (c-)" rating in a research report on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $8.00.

Check Out Our Latest Report on Strata Critical Medical

Strata Critical Medical Company Profile

(Get Free Report)

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Strata Critical Medical Right Now?

Before you consider Strata Critical Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Strata Critical Medical wasn't on the list.

While Strata Critical Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines